Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
Authors:
- Claudia VinciguerraClaudia Vinciguerra
- Liliana BevilacquaLBLiliana Bevilacqua
- Antonino LupicaALAntonino Lupica
- Federica GinanneschiFGFederica Ginanneschi
- Giuseppe PiscosquitoGPGiuseppe Piscosquito
- Nicasio RiniNRNicasio Rini
- Alessandro RossiARAlessandro Rossi
- Paolo BaronePBPaolo Barone
- Filippo BrighinaFilippo Brighina
- Vincenzo Di StefanoVincenzo Di Stefano
Open Access
- 5 September 2023
- journal article
- review article
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1286
Abstract
Myasthenia gravis (MG) is an antibody-mediated neuromuscular disease affecting the neuromuscular junction. In most cases, autoantibodies can be detected in the sera of MG patients, thus aiding in diagnosis and allowing for early screening. However, there is a small proportion of patients who have no detectable auto-antibodies, a condition termed “seronegative MG” (SnMG). Several factors contribute to this, including laboratory test inaccuracies, decreased antibody production, immunosuppressive therapy, immunodeficiencies, antigen depletion, and immune-senescence. The diagnosis of SnMG is more challenging and is based on clinical features and neurophysiological tests. The early identification of these patients is needed in order to ensure early treatment and prevent complications. This narrative review aims to examine the latest updates on SnMG, defining the clinical characteristics of affected patients, diagnostic methods, management, and therapeutic scenarios.Keywords
This publication has 62 references indexed in Scilit:
- LRP 4 antibodies in serum and CSF from amyotrophic lateral sclerosis patientsAnnals of Clinical and Translational Neurology, 2013
- The neuromuscular junction: Selective remodeling of synaptic regulators at the nerve/muscle interfaceMechanisms of Development, 2013
- Electrophysiological and immunological study in myasthenia gravis: Diagnostic sensitivity and correlationClinical Neurophysiology, 2011
- Racial differences in myasthenia gravis in AlabamaMuscle & Nerve, 2009
- Myasthenia Gravis Seronegative for Acetylcholine Receptor AntibodiesAnnals of the New York Academy of Sciences, 2008
- Response to Therapy in Myasthenia Gravis with Anti‐MuSK AntibodiesAnnals of the New York Academy of Sciences, 2008
- IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†Brain, 2008
- Seronegative myasthenia gravis: disease severity and prognosisEuropean Journal of Neurology, 2005
- Seronegative Myasthenia GravisSeminars in Neurology, 2004
- Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert‐Eaton myasthenic syndromeMuscle & Nerve, 2001